Company: SMNR
Filing Date: 2025-08-08
Form Type: S-4/A
Source: 0001193125-25-177097
Chunk: 356

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-08
Form: S-4/A
Chunk 356
---
 |    45,445,903 |     | $      |    49,990,493 |     | $      |    54,989,543 |
| Operating Income (loss)(5)  |     | $      | (7,921,964 | ) |     | $      | (20,952,765 | ) |     | $      | (22,648,280 | ) |     | $      | (66,656,020 | ) |     | $      | 227,248,150 |     | $      |   588,941,925 |     | $      | 2,561,539,478 |     | $      | 3,077,396,585 |     | $      | 3,243,370,260 |     | $      | 3,359,910,826 |

|                             |     | FY2034 |               |     | FY2035 |               |     | FY2036 |               |     | FY2037 |               |     | FY2038 |               |     | FY2039 |               |     | FY2040 |               |     | FY2041 |               |     | FY2042 |               |     | FY2043 |               |
|:----------------------------|:----|:-------|--------------:|:----|:-------|--------------:|:----|:-------|--------------:|:----|:-------|--------------:|:----|:-------|--------------:|:----|:-------|--------------:|:----|:-------|--------------:|:----|:-------|--------------:|:----|:-------|--------------:|:----|:-------|--------------:|
| Gross Sales(1)              |     | $      | 6,622,250,040 |     | $      | 6,854,028,791 |     | $      | 7,093,919,799 |     | $      | 5,601,663,099 |     | $      | 4,094,306,483 |     | $      | 2,571,736,260 |     | $      | 2,584,594,941 |     | $      | 2,597,517,916 |     | $      | 2,610,505,505 |     | $      | 2,623,558,033 |
| Cost of Sales(